Screening for extended-spectrum beta-lactamase-producing pathogenic enterobacteria in district general hospitals [1]

Journal of Clinical Microbiology

Volumn 43, Issue 3, 2005, Pages 1488-1490

  Jonathan, Nteimam ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; PENICILLIN G; QUINOLONE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; DRUG SENSITIVITY; ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTER SAKAZAKII; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE TRANSFER; HOSPITAL; KLEBSIELLA PNEUMONIAE; LETTER; MUTATION; PATHOGENICITY; PRIORITY JOURNAL; SCREENING; UNITED KINGDOM; URINARY TRACT INFECTION;

BETA-LACTAMASES; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HOSPITALS, DISTRICT; HOSPITALS, GENERAL; HUMANS;

BACTERIA (MICROORGANISMS); ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTER SAKAZAKII; ENTEROBACTERIA; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 14944367213     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.3.1488-1490.2005     Document Type: Letter

References (6)

1. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention. 16 September 2004, access date. Laboratory detection of extended-spectrum β-lactamases. [Online.] www.cdc.gov/ncidod/hip/lab/ factsheet /esbl.htm.
2. Health Protection Agency. 2003. Infection with organisms carrying extended-spectrum beta-lactamases in the community: First report. CDR Wkly. 13(32):3.
3. Livermore, D. 2002. Detection of β-lactamase mediated resistance, p. 1-18. In Standardized disc susceptibility method. User day report for November 2002 meeting held at Belfast City Hospital, Belfast. British Society for Antimicrobial Chemotherapy, Birmingham, United Kingdom.
4. Livermore, D. M., and D. F. J. Brown. 2001. Detection of β-lactamase-mediated resistance. J. Antimicrob. Chemother. 48(Suppl. 1):59-64.
5. MacKenzie, F. M., C. A. Miller, and I. M. Gould. 2002. Comparison of screening methods for TEM and SHV derived ESBL production. Clin. Microbiol. Infect. 8:715-724.
6. Navon-Venezia, S., O. Hammer-Munz, D. Schwartz, D. Turner, B. Kuzmenko, and Y. Carmeli. 2003. Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Centre (Israel) and evaluation of diagnostic tests. J. Clin. Microbiol. 41:155-158.